ArticlePharmaceutics2025
Poloxamer-Based Biomaterial as a Pharmaceutical Strategy to Improve the Ivermectin Performance.
Belén Alejandra Mezzano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it